Literature DB >> 3052323

Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature.

M G Ridley1, C S Wolfe, J A Mathews.   

Abstract

A patient is described with definite rheumatoid arthritis (RA) who developed life threatening acute pneumonitis after receiving a total dose of only 12.5 mg methotrexate (MTX). This complication has been previously described, but this is probably the lowest reported dose before development of pneumonitis in a patient with RA. The possible significance of this case is discussed in the light of recent reports suggesting an increased susceptibility of patients with RA to the pulmonary toxicity of MTX.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3052323      PMCID： PMC1003598          DOI： 10.1136/ard.47.9.784

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  15 in total

1.  Methotrexate therapy and pulmonary disease.

Authors:  C S Everts; J L Westcott; D G Bragg
Journal:  Radiology       Date:  1973-06       Impact factor: 11.105

2.  Pulmonary disease complicating intermittent therapy with methotrexate.

Authors:  A M Clarysse; W J Cathey; G E Cartwright; M M Wintrobe
Journal:  JAMA       Date:  1969-09-22       Impact factor: 56.272

3.  Severe pneumonitis occurring during methotrexate therapy. Re- port of two cases.

Authors:  G C Goldman; S L Moschella
Journal:  Arch Dermatol       Date:  1971-02

4.  Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis.

Authors:  J A Engelbrecht; S L Calhoon; J J Scherrer
Journal:  Arthritis Rheum       Date:  1983-10

5.  Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis.

Authors:  G W Cannon; J R Ward; D O Clegg; C O Samuelson; T M Abbott
Journal:  Arthritis Rheum       Date:  1983-10

6.  Pleuropulmonary manifestations of rheumatoid arthritis.

Authors:  W C Shiel; P E Prete
Journal:  Semin Arthritis Rheum       Date:  1984-02       Impact factor: 5.532

7.  Methotrexate pneumonitis in a psoriatic.

Authors:  E From
Journal:  Br J Dermatol       Date:  1975-07       Impact factor: 9.302

8.  Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate.

Authors:  C W Carson; G W Cannon; M J Egger; J R Ward; D O Clegg
Journal:  Semin Arthritis Rheum       Date:  1987-02       Impact factor: 5.532

9.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

10.  A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.

Authors:  R N Thompson; C Watts; J Edelman; J Esdaile; A S Russell
Journal:  J Rheumatol       Date:  1984-12       Impact factor: 4.666
View more
  11 in total

1.  Methotrexate and the rheumatoid lung: a riddle wrapped in an enigma.

Authors:  Mehmet Sirmali; Levent Ozçakar; Göktürk Findik; Ayşen Akinci; Sadi Kaya
Journal:  Rheumatol Int       Date:  2003-10-31       Impact factor: 2.631

2.  Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis.

Authors:  N J Cook; G J Carroll
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 3.  Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.

Authors:  F Salaffi; P Manganelli; M Carotti; S Subiaco; G Lamanna; C Cervini
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

Review 4.  Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?

Authors:  S Tariq; S M Tariq
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

Review 5.  A clinical and economic review of disease-modifying antirheumatic drugs.

Authors:  S E Gabriel; D Coyle; L W Moreland
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 6.  Methotrexate in rheumatoid arthritis. An update.

Authors:  B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

7.  Sustained cough in methotrexate therapy for rheumatoid arthritis.

Authors:  A Schnabel; K Dalhoff; S Bauerfeind; J Barth; W L Gross
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

Review 8.  Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports.

Authors:  M R Hargreaves; A G Mowat; M K Benson
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

9.  Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literature.

Authors:  Nadia D'Andrea; Luca Triolo; Giovanna Margagnoni; Annalisa Aratari; Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2010-10-31

10.  Acute methotrexate toxicity presenting as multiorgan failure and acute pneumonitis: A rare case report.

Authors:  Saurabh Saigal; Ratender K Singh; Banani Poddar
Journal:  Indian J Crit Care Med       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.